The Relationship Between Parkinson's Disease and Gastrointestinal Diseases

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2022 Aug 29

PMID 36034146

Authors

Jiaqi Zeng

Xinchan Wang

Fei Pan

Zhiqi Mao

Affiliations

Soon will be listed here.

Abstract

An increasing number of studies have provided evidence for the hypothesis that the pathogenesis of Parkinson's disease (PD) may derive from the gut. Firstly, Lewy pathology can be induced in the enteric nervous system (ENS) and be transported to the central nervous system (CNS) via the vagal nerve. Secondly, the altered composition of gut microbiota causes an imbalance between beneficial and deleterious microbial metabolites which interacts with the increased gut permeability and the gut inflammation as well as the systemic inflammation. The activated inflammatory status then affects the CNS and promotes the pathology of PD. Given the above-mentioned findings, researchers start to pay attention to the connection between PD and gastrointestinal diseases including irritable bowel syndrome, inflammatory bowel disease (IBD), microscopic colitis (MC), gastrointestinal infections, gastrointestinal neoplasms, and colonic diverticular disease (CDD). This review focuses on the association between PD and gastrointestinal diseases as well as the pathogenesis of PD from the gut.

Citing Articles

Patients' Characteristics Associated With Size of Ruptured and Unruptured Intracranial Aneurysms.

Dinger T, Chihi M, Gumus M, Riess C, Santos A, Moskopp M Brain Behav. 2024; 14(11):e70161.

PMID: 39607092 PMC: 11603431. DOI: 10.1002/brb3.70161.

Gut microbiota from patients with Parkinson's disease causes motor deficits in honeybees.

Zeng J, Li Y, Yan J, Chang R, Xu M, Zhou G Front Microbiol. 2024; 15:1418857.

PMID: 39070266 PMC: 11272988. DOI: 10.3389/fmicb.2024.1418857.

Investigating the molecular mechanisms underlying the co-occurrence of Parkinson's disease and inflammatory bowel disease through the integration of multiple datasets.

Sun Q, Li Y, Ning S Sci Rep. 2024; 14(1):17028.

PMID: 39043798 PMC: 11266657. DOI: 10.1038/s41598-024-67890-1.

Structural brain morphometry differences and similarities between young patients with Crohn's disease in remission and healthy young and old controls.

Yeske B, Hou J, Chu D, Adluru N, Nair V, Beniwal-Patel P Front Neurosci. 2024; 18:1210939.

PMID: 38356645 PMC: 10864509. DOI: 10.3389/fnins.2024.1210939.

Unraveling the transcriptomic signatures of Parkinson's disease and major depression using single-cell and bulk data.

Christodoulou C, Onisiforou A, Zanos P, Zamba Papanicolaou E Front Aging Neurosci. 2023; 15:1273855.

PMID: 38020762 PMC: 10664927. DOI: 10.3389/fnagi.2023.1273855.

References

Kelly C, Zheng L, Campbell E, Saeedi B, Scholz C, Bayless A . Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015; 17(5):662-71. PMC: 4433427. DOI: 10.1016/j.chom.2015.03.005. View

Caldarella M, Serra J, Azpiroz F, Malagelada J . Prokinetic effects in patients with intestinal gas retention. Gastroenterology. 2002; 122(7):1748-55. DOI: 10.1053/gast.2002.33658. View

Lai S, Liao K, Lin C, Sung F . Irritable bowel syndrome correlates with increased risk of Parkinson's disease in Taiwan. Eur J Epidemiol. 2014; 29(1):57-62. DOI: 10.1007/s10654-014-9878-3. View

Jamal S, Kumari A, Singh A, Goyal S, Grover A . Conformational Ensembles of α-Synuclein Derived Peptide with Different Osmolytes from Temperature Replica Exchange Sampling. Front Neurosci. 2017; 11:684. PMC: 5725442. DOI: 10.3389/fnins.2017.00684. View

Zheng S, Li H, Xu R, Miao W, Dai M, Ding S . Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Ageing Res Rev. 2021; 69:101347. DOI: 10.1016/j.arr.2021.101347. View

Lin C, Chen C, Chiang H, Liou J, Chang C, Lu T . Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease. J Neuroinflammation. 2019; 16(1):129. PMC: 6598278. DOI: 10.1186/s12974-019-1528-y. View

Uversky V, Li J, Fink A . Trimethylamine-N-oxide-induced folding of alpha-synuclein. FEBS Lett. 2001; 509(1):31-5. DOI: 10.1016/s0014-5793(01)03121-0. View

Phani S, Loike J, Przedborski S . Neurodegeneration and inflammation in Parkinson's disease. Parkinsonism Relat Disord. 2011; 18 Suppl 1:S207-9. DOI: 10.1016/S1353-8020(11)70064-5. View

Manasanch E, Orlowski R . Proteasome inhibitors in cancer therapy. Nat Rev Clin Oncol. 2017; 14(7):417-433. PMC: 5828026. DOI: 10.1038/nrclinonc.2016.206. View

10.

Horsager J, Andersen K, Knudsen K, Skjaerbaek C, Fedorova T, Okkels N . Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain. 2020; 143(10):3077-3088. DOI: 10.1093/brain/awaa238. View

11.

Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T . Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014. Gut. 2018; 68(1):18-24. DOI: 10.1136/gutjnl-2017-315666. View

12.

Mishima T, Fukae J, Fujioka S, Inoue K, Tsuboi Y . The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson's Disease Patients According to Rome III Diagnostic Criteria. J Parkinsons Dis. 2017; 7(2):353-357. PMC: 5438471. DOI: 10.3233/JPD-160982. View

13.

Khalili H, Burke K, Roelstraete B, Sachs M, Olen O, Ludvigsson J . Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study. Gastroenterology. 2020; 158(6):1574-1583.e2. DOI: 10.1053/j.gastro.2019.12.028. View

14.

Unger M, Spiegel J, Dillmann K, Grundmann D, Philippeit H, Burmann J . Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat Disord. 2016; 32:66-72. DOI: 10.1016/j.parkreldis.2016.08.019. View

15.

Nielsen H, Qiu J, Friis S, Wermuth L, Ritz B . Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark. Eur J Neurol. 2012; 19(6):864-9. PMC: 3330170. DOI: 10.1111/j.1468-1331.2011.03643.x. View

16.

Zhang X, Svn Z, Liv M, Yang Y, Zeng R, Huang Q . Association Between Irritable Bowel Syndrome and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis. Front Neurol. 2021; 12:720958. PMC: 8492947. DOI: 10.3389/fneur.2021.720958. View

17.

Sankowski B, Ksiezarczyk K, Rackowska E, Szlufik S, Koziorowski D, Giebultowicz J . Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson's disease. Clin Chim Acta. 2019; 501:165-173. DOI: 10.1016/j.cca.2019.10.038. View

18.

Leikas J, Kohtala S, Theilmann W, Jalkanen A, Forsberg M, Rantamaki T . Brief isoflurane anesthesia regulates striatal AKT-GSK3β signaling and ameliorates motor deficits in a rat model of early-stage Parkinson's disease. J Neurochem. 2017; 142(3):456-463. PMC: 5575520. DOI: 10.1111/jnc.14066. View

19.

Chung S, Rim J, Ji D, Lee S, Yoo H, Jung J . Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease. Nutrition. 2021; 83:111090. DOI: 10.1016/j.nut.2020.111090. View

20.

Cakmak Y . Provotella-derived hydrogen sulfide, constipation, and neuroprotection in Parkinson's disease. Mov Disord. 2015; 30(8):1151. DOI: 10.1002/mds.26258. View